ATE128129T1
(en)
|
1986-07-28 |
1995-10-15 |
American Cyanamid Co |
5(AND/OR6) SUBSTITUTED 2-(2-IMIDAZOLINE-2-YL) NICOTINIC ACIDS, ESTERS AND SALTS USABLE AS HERBICIDAL AGENTS AND INTERMEDIATE COMPOUNDS FOR THE PRODUCTION OF THESE NICOTINIC ACIDS, ESTERS AND SALTS.
|
FR2624698A1
(en)
|
1987-12-18 |
1989-06-23 |
Bernard Lyon I Universite Clau |
HETEROCYCLIC DERIVATIVES OF N-CARBAMOYL-, N-THIOCARBAMOYL- OR N-AMIDINO-AMINOMALONYL OR AMINOSUCCINYL AMIDES USEFUL AS SULFURING AGENTS
|
EP0462179A4
(en)
|
1989-02-27 |
1992-03-18 |
The Du Pont Merck Pharmaceutical Company |
Novel sulfonamides as radiosensitizers
|
US5776963A
(en)
|
1989-05-19 |
1998-07-07 |
Hoechst Marion Roussel, Inc. |
3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
|
GB8927872D0
(en)
|
1989-12-08 |
1990-02-14 |
Beecham Group Plc |
Pharmaceuticals
|
JP2807577B2
(en)
|
1990-06-15 |
1998-10-08 |
エーザイ株式会社 |
Cyclic amide derivative
|
DE4121214A1
(en)
|
1991-06-27 |
1993-01-14 |
Bayer Ag |
7-AZAISOINDOLINYL CHINOLONE AND NAPHTHYRIDONE CARBONIC ACID DERIVATIVES
|
EP0520573A1
(en)
|
1991-06-27 |
1992-12-30 |
Glaxo Inc. |
Cyclic imide derivatives
|
US5272158A
(en)
|
1991-10-29 |
1993-12-21 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
US5416099A
(en)
|
1991-10-29 |
1995-05-16 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
US5389631A
(en)
|
1991-10-29 |
1995-02-14 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
US5238950A
(en)
|
1991-12-17 |
1993-08-24 |
Schering Corporation |
Inhibitors of platelet-derived growth factor
|
US5364869A
(en)
|
1992-03-09 |
1994-11-15 |
Abbott Laboratories |
Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists
|
US5326760A
(en)
|
1992-06-29 |
1994-07-05 |
Glaxo, Inc. |
Aminobutanoic acid compounds having metalloprotease inhibiting properties
|
JPH06236056A
(en)
|
1993-02-10 |
1994-08-23 |
Fuji Xerox Co Ltd |
Electrophotographic sensitive body
|
JP3760474B2
(en)
|
1993-04-22 |
2006-03-29 |
ダイキン工業株式会社 |
Method and apparatus for generating electric energy, and compound having NF bond used therefor
|
CA2134192A1
(en)
|
1993-11-12 |
1995-05-13 |
Michael L. Denney |
5, 6-bicyclic glycoprotein iib/iiia antagonists
|
DE4343922A1
(en)
|
1993-12-22 |
1995-06-29 |
Basf Ag |
Pyridine-2,3-dicarboximides, process for their preparation and their use in combating undesirable plant growth
|
KR970007419B1
(en)
|
1993-12-30 |
1997-05-08 |
한솔제지 주식회사 |
Subliming type dye for thermal transfer printing
|
FR2725946A1
(en)
|
1994-10-24 |
1996-04-26 |
Lohr Ind |
Vehicle chock, for use on transporters with perforated carrying surfaces,
|
US5719144A
(en)
|
1995-02-22 |
1998-02-17 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
DE69628484T2
(en)
|
1995-03-24 |
2004-05-19 |
Takeda Chemical Industries, Ltd. |
Cyclic compounds, their preparation and their use as tachykinin receptor antagonists
|
US5770590A
(en)
|
1995-03-24 |
1998-06-23 |
Takeda Chemical Industries, Ltd. |
Cyclic compounds, their prudiction and use
|
AU722514B2
(en)
|
1995-12-28 |
2000-08-03 |
Fujisawa Pharmaceutical Co., Ltd. |
Benzimidazole derivatives
|
DE19608791A1
(en)
|
1996-03-07 |
1997-09-11 |
Hoechst Ag |
Process for the preparation of fluorinated aromatics and fluorinated nitrogen-containing heteroaromatics
|
DE19702282C2
(en)
|
1997-01-23 |
1998-11-19 |
Hoechst Ag |
Catalyst for Halex reactions
|
US6177443B1
(en)
|
1997-03-07 |
2001-01-23 |
Novo Nordisk A/S |
4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
|
JP2001514631A
(en)
|
1997-03-07 |
2001-09-11 |
ノボ ノルディスク アクティーゼルスカブ |
4,5,6,7-tetrahydro-thieno [3,2-c] pyridine derivatives, their production and use
|
KR19980074060A
(en)
|
1997-03-21 |
1998-11-05 |
김윤배 |
Novel substituted 3,4-dialkoxyphenyl derivatives
|
JPH1143489A
(en)
|
1997-05-30 |
1999-02-16 |
Takeda Chem Ind Ltd |
Heterocyclic compound, its production and agent
|
EP1061926A2
(en)
|
1998-03-19 |
2000-12-27 |
Takeda Chemical Industries, Ltd. |
Heterocyclic compounds, their production and use as tachykinin receptor antagonists
|
US20020132817A1
(en)
|
1998-03-19 |
2002-09-19 |
Hideaki Natsugari |
Heterocyclic compounds, their production and use
|
FR2778662B1
(en)
|
1998-05-12 |
2000-06-16 |
Adir |
NOVEL SUBSTITUTED CYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
JP2000007661A
(en)
|
1998-06-23 |
2000-01-11 |
Nippon Nohyaku Co Ltd |
Heterocyclic diamide dicarboxylate derivative, its intermediate and herbicide
|
CA2338827A1
(en)
|
1998-07-28 |
2000-02-10 |
Hideo Takaishi |
Fused heterocyclic dicarboxylic acids diamide derivatives or salts thereof, herbicide and method for using the same
|
US6348032B1
(en)
|
1998-11-23 |
2002-02-19 |
Cell Pathways, Inc. |
Method of inhibiting neoplastic cells with benzimidazole derivatives
|
WO2000032192A1
(en)
|
1998-11-27 |
2000-06-08 |
Takeda Chemical Industries, Ltd. |
Drugs
|
WO2000067754A1
(en)
|
1999-05-12 |
2000-11-16 |
Nitromed, Inc. |
Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
|
CA2377085C
(en)
|
1999-06-23 |
2011-02-15 |
Aventis Pharma Deutschland Gmbh |
Substituted benzimidazoles
|
CN1361779A
(en)
|
1999-07-21 |
2002-07-31 |
阿斯特拉曾尼卡有限公司 |
New compounds
|
TR200200263T2
(en)
|
1999-08-02 |
2004-12-21 |
F.Hoffmann-La Roche Ag |
New selective retinoid agonists
|
ATE402937T1
(en)
|
1999-11-09 |
2008-08-15 |
Abbott Lab |
HYDROMORPHINONE AND HYDROCODEINONE COMPOSITIONS AND METHODS FOR THEIR SYNTHESIS
|
US6770666B2
(en)
|
1999-12-27 |
2004-08-03 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs
|
CA2363274A1
(en)
|
1999-12-27 |
2001-07-05 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs for hepatitis c
|
WO2001051128A1
(en)
|
2000-01-12 |
2001-07-19 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
JP2003531894A
(en)
|
2000-04-25 |
2003-10-28 |
サムスン エレクトロニクス カンパニー リミテッド |
Biphenylbutyric acid derivatives as matrix metalloprotease inhibitors
|
JP3785094B2
(en)
|
2000-05-02 |
2006-06-14 |
エフ.ホフマン−ラ ロシュ アーゲー |
New gamma-selective retinoids
|
AU2001264566A1
(en)
|
2000-05-05 |
2001-11-20 |
Cor Therapeutics, Inc. |
Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
|
US6552015B2
(en)
|
2000-08-03 |
2003-04-22 |
Pfizer Inc. |
Azabicycloalkane derivatives and therapeutic uses thereof
|
JP2004509867A
(en)
|
2000-09-19 |
2004-04-02 |
サントル、ナショナール、ド、ラ、ルシェルシュ、シアンティフィク、(セーエヌエルエス) |
Pyridinone and pyridinethione derivatives having HIV inhibitory properties
|
US6884782B2
(en)
|
2000-11-08 |
2005-04-26 |
Amgen Inc. |
STAT modulators
|
US6677365B2
(en)
|
2001-04-03 |
2004-01-13 |
Telik, Inc. |
Antagonists of MCP-1 function and methods of use thereof
|
WO2002081447A1
(en)
|
2001-04-06 |
2002-10-17 |
Daewoong Pharmaceutical Co., Ltd. |
3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof
|
ES2278016T3
(en)
|
2001-04-09 |
2007-08-01 |
Novartis Vaccines And Diagnostics, Inc. |
GUANIDINE COMPOUNDS AS AGONISTS OF THE RECEIVER OF MELANOCORTINA 4 (MC4-R).
|
CA2446924C
(en)
|
2001-04-19 |
2011-02-08 |
Eisai Co., Ltd. |
2-iminopyrrolidine derivatives
|
CN1951939A
(en)
|
2001-05-24 |
2007-04-25 |
伊莱利利公司 |
Novel pyrrole derivatives as pharmaceutical agents
|
CN1250550C
(en)
|
2001-07-16 |
2006-04-12 |
盐野义制药株式会社 |
Process for preparation of amidine derivatives
|
US6627646B2
(en)
*
|
2001-07-17 |
2003-09-30 |
Sepracor Inc. |
Norastemizole polymorphs
|
JP2003171380A
(en)
|
2001-09-28 |
2003-06-20 |
Takeda Chem Ind Ltd |
Method for producing tricyclic compound
|
WO2003029254A1
(en)
|
2001-09-28 |
2003-04-10 |
Takeda Chemical Industries, Ltd. |
Process for preparation of tricyclic compounds
|
IL160884A0
(en)
|
2001-10-02 |
2004-08-31 |
Upjohn Co |
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
|
DE10156719A1
(en)
|
2001-11-19 |
2003-05-28 |
Bayer Ag |
New N-(aza-bicycloalkyl)-benzo-heterocyclic carboxamides, useful as Alpha-7-nicotinic acetylcholine receptor ligands for e.g. improving attention, concentration, learning and/or memory performance
|
TWI263640B
(en)
|
2001-12-19 |
2006-10-11 |
Bristol Myers Squibb Co |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
|
BR0307441A
(en)
|
2002-02-04 |
2005-01-04 |
Hoffmann La Roche |
Compounds, process for preparing a compound, pharmaceutical composition, use of such compounds, method for treating and prophylaxis of diseases and method for treating obesity
|
DE10207037A1
(en)
|
2002-02-20 |
2003-08-28 |
Bayer Cropscience Gmbh |
New 2-amino-4-(bicyclic substituted amino)-1,3,5-triazine derivatives, useful as pre- or post-emergence, total or selective herbicides or as plant growth regulators
|
US7189851B2
(en)
|
2002-03-06 |
2007-03-13 |
Smithkline Beecham Corporation |
Condensed heterocyclic compounds as calcitonin agonists
|
WO2003104216A1
(en)
|
2002-06-10 |
2003-12-18 |
Acadia Pharmaceuticals Inc. |
Urotensin ii receptor modulators
|
AU2003250482A1
(en)
|
2002-08-13 |
2004-02-25 |
Warner-Lambert Company Llc |
Phthalimide derivatives as matrix metalloproteinase inhibitors
|
ES2291664T3
(en)
|
2002-09-17 |
2008-03-01 |
Eli Lilly And Company |
DERIVATIVES OF PIRAZOLOPIRIDINE AS INHIBITORS OF TGF BETA SIGNAL TRANSDUCTION FOR CANCER TREATMENT.
|
WO2004042029A2
(en)
|
2002-11-05 |
2004-05-21 |
Isis Pharmaceuticals, Inc. |
Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use
|
JP2004203791A
(en)
|
2002-12-25 |
2004-07-22 |
Dai Ichi Seiyaku Co Ltd |
Aromatic compound
|
CN1212674C
(en)
|
2003-01-08 |
2005-07-27 |
东南大学 |
Transverse buffer P-type MOS transistors
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
GB0308025D0
(en)
|
2003-04-07 |
2003-05-14 |
Glaxo Group Ltd |
Compounds
|
PE20050158A1
(en)
|
2003-05-19 |
2005-05-12 |
Irm Llc |
IMMUNOSUPPRESSOR COMPOUNDS AND COMPOSITIONS
|
WO2004103309A2
(en)
|
2003-05-19 |
2004-12-02 |
Irm Llc |
Immunosuppressant compounds and compositions
|
MXPA05012460A
(en)
|
2003-05-19 |
2006-05-25 |
Irm Llc |
Immunosuppressant compounds and compositions.
|
MY150088A
(en)
|
2003-05-19 |
2013-11-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
JP2006526660A
(en)
|
2003-06-05 |
2006-11-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
VR1 receptor modulators
|
CN1566099A
(en)
|
2003-06-13 |
2005-01-19 |
中国科学院上海药物研究所 |
Isoquinoline-1,3,4-trione compounds, preparation method and uses thereof
|
WO2005005392A1
(en)
|
2003-07-07 |
2005-01-20 |
Ionix Pharmaceuticals Limited |
Azacyclic compounds as inhibitors of sensory neurone specific channels
|
FR2857966A1
(en)
|
2003-07-24 |
2005-01-28 |
Aventis Pharma Sa |
New piperazine and tetrahydropyridine derivatives are tubulin polymerization inhibitors used for treating cancer and disaggregating cell masses derived from vascular tissue
|
CA2533554A1
(en)
|
2003-08-01 |
2005-02-10 |
Pfizer Products Inc. |
6-membered heteroaryl compounds for the treatment of neurodegenerative disorders
|
US20050070542A1
(en)
|
2003-09-03 |
2005-03-31 |
Hodgetts Kevin J. |
5-Aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds
|
ZA200601978B
(en)
|
2003-09-05 |
2007-05-30 |
Neurogen Corp |
Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligands
|
US20070088163A1
(en)
|
2003-09-12 |
2007-04-19 |
Kemia, Inc. |
Modulators of calcitonin and amylin activity
|
US20050182061A1
(en)
|
2003-10-02 |
2005-08-18 |
Jeremy Green |
Phthalimide compounds useful as protein kinase inhibitors
|
AU2004293017B2
(en)
|
2003-11-19 |
2010-08-19 |
Array Biopharma Inc. |
Bicyclic inhibitors of MEK and methods of use thereof
|
US7732616B2
(en)
|
2003-11-19 |
2010-06-08 |
Array Biopharma Inc. |
Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
|
US20050203151A1
(en)
|
2003-12-19 |
2005-09-15 |
Kalypsys, Inc. |
Novel compounds, compositions and uses thereof for treatment of metabolic disorders and related conditions
|
JP2007516275A
(en)
|
2003-12-23 |
2007-06-21 |
ファイザー・プロダクツ・インク |
Therapeutic combinations for cognitive enhancement and psychotic disorders
|
JP2007531744A
(en)
|
2004-04-05 |
2007-11-08 |
武田薬品工業株式会社 |
6-azaindole compounds
|
WO2005100334A1
(en)
|
2004-04-14 |
2005-10-27 |
Pfizer Products Inc. |
Dipeptidyl peptidase-iv inhibitors
|
GB0412467D0
(en)
|
2004-06-04 |
2004-07-07 |
Astrazeneca Ab |
Chemical compounds
|
EP1809622B1
(en)
|
2004-09-22 |
2010-07-21 |
Janssen Pharmaceutica N.V. |
Inhibitors of the interaction between mdm2 and p53
|
US20060128710A1
(en)
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
WO2006065842A2
(en)
|
2004-12-13 |
2006-06-22 |
Synta Pharmaceuticals Corp. |
5,6,7,8-tetrahydroquinolines and related compounds and uses thereof
|
EP1838320B1
(en)
|
2005-01-07 |
2014-07-16 |
Emory University |
Cxcr4 antagonists for the treatment of medical disorders
|
BRPI0607311A2
(en)
|
2005-02-07 |
2009-08-25 |
Hoffmann La Roche |
heterocyclyl-substituted phenyl methanones as glycine transporter inhibitors 1
|
GB0504556D0
(en)
|
2005-03-04 |
2005-04-13 |
Pfizer Ltd |
Novel pharmaceuticals
|
PL1877379T3
(en)
|
2005-04-13 |
2013-06-28 |
Astex Therapeutics Ltd |
Hydroxybenzamide derivatives and their use as inhibitors of hsp90
|
WO2007050124A1
(en)
|
2005-05-19 |
2007-05-03 |
Xenon Pharmaceuticals Inc. |
Fused piperidine derivatives and their uses as therapeutic agents
|
WO2007007054A1
(en)
|
2005-07-08 |
2007-01-18 |
Cancer Research Technology Limited |
Phthalamides, succinimides and related compounds and their use as pharmaceuticals
|
CA2619462A1
(en)
|
2005-08-16 |
2007-02-22 |
Amgen, Inc. |
Phosphodiesterase 10 inhibitors
|
DE602006021044D1
(en)
|
2005-09-29 |
2011-05-12 |
Glaxo Group Ltd |
PYRAZOLOÄ3,4-BÜPYRIDIN COMPOUNDS AND THEIR USE AS PDE4 INHIBITORS
|
KR101318127B1
(en)
|
2005-11-10 |
2013-10-16 |
엠에스디 가부시키가이샤 |
Aza-substituted spiro derivative
|
PE20071241A1
(en)
|
2006-01-17 |
2008-01-14 |
Schering Corp |
HYDANTOIN-DERIVED COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
|
WO2007084815A2
(en)
|
2006-01-19 |
2007-07-26 |
Janssen Pharmaceutica, N.V. |
Substituted thienopyrimidine kinase inhibitors
|
US7750034B2
(en)
|
2006-01-25 |
2010-07-06 |
Merck Sharp & Dohme Corp. |
Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
AU2007218053B2
(en)
|
2006-02-15 |
2010-05-27 |
Merck Sharp & Dohme Corp. |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
AU2007220040A1
(en)
|
2006-02-27 |
2007-09-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods to identify inhibitors of the unfolded protein response
|
US7977351B2
(en)
|
2006-03-22 |
2011-07-12 |
Allergan, Inc. |
Heteroaryl dihydroindolones as kinase inhibitors
|
WO2007107545A1
(en)
|
2006-03-22 |
2007-09-27 |
Janssen Pharmaceutica N.V. |
Cyclic-alkylaminederivatives as inhibitors of the interaction between mdm2 and p53
|
EP2023919A4
(en)
|
2006-05-08 |
2010-12-22 |
Molecular Neuroimaging Llc |
Compounds and amyloid probes thereof for therapeutic and imaging uses
|
WO2007131982A2
(en)
|
2006-05-16 |
2007-11-22 |
Boehringer Ingelheim International Gmbh |
Substituted prolinamides, production thereof and their use as drugs
|
CN1869036A
(en)
|
2006-06-30 |
2006-11-29 |
中国药科大学 |
7-substituted-3-chloro pyrrolo [3,4-b] pyridine compound
|
DE102006032824A1
(en)
|
2006-07-14 |
2008-01-17 |
Bayer Healthcare Ag |
Substituted indazoles
|
WO2008010964A1
(en)
|
2006-07-17 |
2008-01-24 |
Merck & Co., Inc. |
1-hydroxy naphthyridine compounds as anti-hiv agents
|
US9102622B2
(en)
|
2006-07-28 |
2015-08-11 |
University Of Connecticut |
Fatty acid amide hydrolase inhibitors
|
US8389739B1
(en)
|
2006-10-05 |
2013-03-05 |
Orphagen Pharmaceuticals |
Modulators of retinoid-related orphan receptor gamma
|
US9730912B2
(en)
|
2006-10-12 |
2017-08-15 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
WO2008044029A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
EP2081891A2
(en)
|
2006-10-12 |
2009-07-29 |
Astex Therapeutics Limited |
Pharmaceutical compounds having hsp90 inhibitory or modulating activity
|
JP5528807B2
(en)
|
2006-10-12 |
2014-06-25 |
アステックス、セラピューティックス、リミテッド |
Compound drug
|
WO2008044041A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
AR063311A1
(en)
|
2006-10-18 |
2009-01-21 |
Novartis Ag |
ORGANIC COMPOUNDS
|
AU2007333234A1
(en)
|
2006-12-11 |
2008-06-19 |
Novartis Ag |
Method of preventing or treating myocardial ischemia
|
WO2008083070A1
(en)
|
2006-12-29 |
2008-07-10 |
Neurogen Corporation |
Crf1 receptor ligands comprising fused bicyclic heteroaryl moieties
|
EP2111227A1
(en)
|
2007-01-08 |
2009-10-28 |
Phenomix Corporation |
Macrocyclic hepatitis c protease inhibitors
|
WO2009004496A2
(en)
|
2007-04-13 |
2009-01-08 |
University Of Manitoba |
Bisanthrapyrazoles as anti-cancer agents
|
US20110189167A1
(en)
|
2007-04-20 |
2011-08-04 |
Flynn Daniel L |
Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
|
US20100129933A1
(en)
|
2007-04-26 |
2010-05-27 |
Forschungszentrum Karlsruhe Gmbh |
Method for detecting the binding between mdm2 and the proteasome
|
TW200902533A
(en)
|
2007-05-02 |
2009-01-16 |
Boehringer Ingelheim Int |
Carboxylic acid amides, manufacturing and use thereof as medicaments
|
WO2008135524A2
(en)
|
2007-05-02 |
2008-11-13 |
Boehringer Ingelheim International Gmbh |
Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
|
CN104017241B
(en)
|
2007-05-10 |
2017-09-05 |
塑料包装有限公司 |
Oxygen removes molecule, the product and its application method of molecule is removed comprising the oxygen
|
TW200902499A
(en)
|
2007-05-15 |
2009-01-16 |
Astrazeneca Ab |
New compounds
|
GB0710844D0
(en)
|
2007-06-06 |
2007-07-18 |
Lectus Therapeutics Ltd |
Potassium ion channel modulators & uses thereof
|
DE102007034620A1
(en)
|
2007-07-25 |
2009-01-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New B1 antagonists
|
WO2009026248A2
(en)
|
2007-08-17 |
2009-02-26 |
The Government Of The United States, As Represented By The Secretary Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer |
Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase
|
TWI534137B
(en)
|
2007-09-17 |
2016-05-21 |
艾伯維巴哈馬有限公司 |
Anti-infective agents and uses thereof
|
US20090076275A1
(en)
|
2007-09-19 |
2009-03-19 |
David Robert Bolin |
Diacylglycerol acyltransferase inhibitors
|
WO2009049154A1
(en)
|
2007-10-11 |
2009-04-16 |
Smithkline Beecham Corporation |
NOVEL sEH INHIBITORS AND THEIR USE
|
CA2702950A1
(en)
|
2007-10-16 |
2009-04-23 |
Northeastern University |
Methods and compounds for modulating cannabinoid activity
|
WO2009050228A2
(en)
|
2007-10-18 |
2009-04-23 |
Novartis Ag |
Csf-1r inhibitors for treatment of cancer and bone diseases
|
KR101196543B1
(en)
|
2007-11-29 |
2012-11-01 |
에프. 호프만-라 로슈 아게 |
Process for the preparation of isoindole derivatives as well as a process for the preparation of their intermediates
|
WO2009073788A1
(en)
|
2007-12-07 |
2009-06-11 |
Firestone Leigh H |
Compositions and methods for treating menopausal females
|
EP2078711A1
(en)
|
2007-12-28 |
2009-07-15 |
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. |
(Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
|
GB0800035D0
(en)
|
2008-01-02 |
2008-02-13 |
Glaxo Group Ltd |
Compounds
|
FR2926554B1
(en)
|
2008-01-22 |
2010-03-12 |
Sanofi Aventis |
AZABICYCLIC CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
|
CN101225070B
(en)
|
2008-01-31 |
2010-04-14 |
上海交通大学 |
Antineoplastic medicament
|
PT2242740E
(en)
|
2008-02-05 |
2013-02-06 |
Sanofi Sa |
Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments
|
WO2009112445A1
(en)
|
2008-03-10 |
2009-09-17 |
Novartis Ag |
Method of increasing cellular phosphatidyl choline by dgat1 inhibition
|
GB0804702D0
(en)
|
2008-03-13 |
2008-04-16 |
Amura Therapeutics Ltd |
Compounds
|
GB0804701D0
(en)
|
2008-03-13 |
2008-04-16 |
Amura Therapeutics Ltd |
Compounds
|
WO2009124755A1
(en)
|
2008-04-08 |
2009-10-15 |
European Molecular Biology Laboratory (Embl) |
Compounds with novel medical uses and method of identifying such compounds
|
US8309577B2
(en)
|
2008-04-23 |
2012-11-13 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
|
US7863291B2
(en)
|
2008-04-23 |
2011-01-04 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
GB0809776D0
(en)
|
2008-05-29 |
2008-07-09 |
Amura Therapeutics Ltd |
Compounds
|
CA2727252A1
(en)
|
2008-07-01 |
2010-01-07 |
Genentech, Inc. |
Isoindolone derivatives as mek kinase inhibitors and methods of use
|
EP2331499B1
(en)
|
2008-08-19 |
2016-09-21 |
Janssen Pharmaceutica NV |
Cold menthol receptor antagonists
|
EP2327704A4
(en)
|
2008-08-29 |
2012-05-09 |
Shionogi & Co |
Ring-fused azole derivative having pi3k-inhibiting activity
|
EP2334183A4
(en)
|
2008-09-16 |
2012-06-06 |
Merck Sharp & Dohme |
Sulfonamide derivative metabotropic glutamate r4 ligands
|
US20100125081A1
(en)
|
2008-11-14 |
2010-05-20 |
Astrazeneca Ab |
New compounds 574
|
WO2010056195A1
(en)
|
2008-11-14 |
2010-05-20 |
Astrazeneca Ab |
New compounds 575
|
CN101455661B
(en)
|
2008-11-19 |
2012-10-10 |
中国科学院上海有机化学研究所 |
Use of 3-substituted phthalide and the analogue
|
NZ593937A
(en)
|
2008-12-08 |
2014-05-30 |
Vm Pharma Llc |
Compositions of protein receptor tyrosine kinase inhibitors
|
ES2406131T3
(en)
|
2009-01-28 |
2013-06-05 |
Bayer Intellectual Property Gmbh |
Fungicidal derivatives of N-cycloalkyl-N-bicyclomethylene-carboxamine
|
WO2011078143A1
(en)
|
2009-12-22 |
2011-06-30 |
塩野義製薬株式会社 |
Pyrimidine derivatives and pharmaceutical composition containing same
|
US20130158072A1
(en)
|
2010-01-19 |
2013-06-20 |
Research Triangle Institute |
Kappa opioid receptor binding ligands
|
US20130045992A1
(en)
|
2010-01-28 |
2013-02-21 |
President And Fellows Of Harvard College |
Compositions and Methods for Enhancing Proteasome Activity
|
EP2368886A1
(en)
|
2010-03-01 |
2011-09-28 |
Phenex Pharmaceuticals AG |
Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease
|
CN102241621A
(en)
|
2010-05-11 |
2011-11-16 |
江苏恒瑞医药股份有限公司 |
5,5-disubstituted-2-iminopyrrolidine derivatives, preparation method thereof, and medical applications thereof
|
EP2571876B1
(en)
|
2010-05-21 |
2016-09-07 |
Merck Sharp & Dohme Corp. |
Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
|
DK2582674T3
(en)
|
2010-06-16 |
2014-12-15 |
Cymabay Therapeutics Inc |
GPR120 receptor agonists and uses thereof.
|
US8299117B2
(en)
|
2010-06-16 |
2012-10-30 |
Metabolex Inc. |
GPR120 receptor agonists and uses thereof
|
WO2012027965A1
(en)
|
2010-09-01 |
2012-03-08 |
Glaxo Group Limited |
Novel compounds
|
WO2012028100A1
(en)
|
2010-09-01 |
2012-03-08 |
Glaxo Group Limited |
Novel compounds
|
AR082885A1
(en)
|
2010-09-03 |
2013-01-16 |
Genentech Inc |
COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
|
CN103119035B
(en)
|
2010-09-27 |
2015-09-30 |
雅培股份有限两合公司 |
Heterogeneous ring compound and they are as the purposes of GSK-3 inhibitor
|
JP2013253019A
(en)
|
2010-09-28 |
2013-12-19 |
Kowa Co |
New piperidine derivative and pharmaceutical containing the same
|
AU2011326071A1
(en)
|
2010-11-08 |
2013-05-23 |
Lycera Corporation |
N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of RORy activity and the treatment of diseases
|
EP2638034A1
(en)
|
2010-11-10 |
2013-09-18 |
Grünenthal GmbH |
Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
|
WO2012100732A1
(en)
|
2011-01-24 |
2012-08-02 |
Glaxo Group Limited |
Retinoid-related orphan receptor gamma modulators, composition containing them and uses thereof
|
WO2012100734A1
(en)
|
2011-01-24 |
2012-08-02 |
Glaxo Group Limited |
Compounds useful as retinoid-related orphan receptor gamma modulators
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
CN102180780A
(en)
|
2011-03-07 |
2011-09-14 |
中国科学技术大学 |
Indenone derivative and applications thereof as developing agent and aggregation inhibitor of amyloid protein deposit and neurofibrillary tangle
|
US9090568B2
(en)
|
2011-03-14 |
2015-07-28 |
Impact Therapeutics, Inc. |
Quinazolinediones and their use
|
CA2831146C
(en)
|
2011-03-25 |
2019-06-04 |
Abbvie Inc. |
Trpv1 antagonists
|
WO2012136296A1
(en)
|
2011-04-04 |
2012-10-11 |
Merck Patent Gmbh |
Metal complexes
|
EP2511263A1
(en)
|
2011-04-14 |
2012-10-17 |
Phenex Pharmaceuticals AG |
Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
|
JP5902029B2
(en)
|
2011-04-28 |
2016-04-13 |
日本たばこ産業株式会社 |
Amide compounds and their pharmaceutical uses
|
US9938269B2
(en)
|
2011-06-30 |
2018-04-10 |
Abbvie Inc. |
Inhibitor compounds of phosphodiesterase type 10A
|
US20140256740A1
(en)
|
2011-07-29 |
2014-09-11 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
EP2736330A4
(en)
|
2011-07-29 |
2015-05-27 |
Tempero Pharmaceuticals Inc |
Compounds and methods
|
US20140155419A1
(en)
|
2011-07-29 |
2014-06-05 |
Erkan Baloglu |
Compounds and methods
|
JP6054869B2
(en)
|
2011-07-29 |
2016-12-27 |
武田薬品工業株式会社 |
Heterocyclic compounds
|
EP2736332A4
(en)
|
2011-07-29 |
2015-03-18 |
Tempero Pharmaceuticals Inc |
Compounds and methods
|
WO2013029338A1
(en)
|
2011-09-01 |
2013-03-07 |
Glaxo Group Limited |
Novel compounds
|
WO2013042782A1
(en)
|
2011-09-22 |
2013-03-28 |
武田薬品工業株式会社 |
Condensed heterocyclic compound
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
WO2013067036A1
(en)
|
2011-10-31 |
2013-05-10 |
Rutgers, The State University Of New Jersey |
Direct inhibitors of keap1-nrf2 interaction as antioxidant inflammation modulators
|
WO2013064231A1
(en)
|
2011-10-31 |
2013-05-10 |
Phenex Pharmaceuticals Ag |
SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
|
US20140249196A1
(en)
|
2011-11-22 |
2014-09-04 |
Theodore Mark Kamenecka |
N-benzylbenzimidazole modulators of pparg
|
WO2013078240A1
(en)
|
2011-11-22 |
2013-05-30 |
Ripka Amy S |
N-biphenylmethylbenzimidazole modulators of pparg
|
JP5918859B2
(en)
|
2011-12-02 |
2016-05-18 |
フェネックス ファーマシューティカルス アーゲー |
Pyrrolocarboxamide for the treatment of chronic inflammatory and autoimmune diseases as a modulator of orphan receptor-gamma (RORγ, NR1F3) activity associated with the orphan nuclear receptor RAR
|
US8741892B2
(en)
|
2011-12-05 |
2014-06-03 |
Boehringer Ingelheim International Gmbh |
Compounds
|
US8642774B2
(en)
|
2011-12-08 |
2014-02-04 |
Boehringer Ingelheim International Gmbh |
Compounds
|
US8796467B2
(en)
|
2011-12-13 |
2014-08-05 |
Boehringer Ingelheim International Gmbh |
Compounds
|
WO2013092460A1
(en)
|
2011-12-20 |
2013-06-27 |
Syngenta Participations Ag |
Cyclic bisoxime microbicides
|
WO2013096496A2
(en)
|
2011-12-21 |
2013-06-27 |
Allergan, Inc. |
Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
|
US9216988B2
(en)
|
2011-12-22 |
2015-12-22 |
Genentech, Inc. |
Benzyl sulfonamide derivatives as RORc modulators
|
US20130190356A1
(en)
|
2011-12-22 |
2013-07-25 |
Genentech, Inc. |
Benzyl sulfonamide derivatives as rorc modulators
|
WO2013100027A1
(en)
|
2011-12-28 |
2013-07-04 |
武田薬品工業株式会社 |
Heterocyclic compound
|
US9321750B2
(en)
|
2012-04-20 |
2016-04-26 |
Innov17 Llc |
ROR modulators and their uses
|
TWI593678B
(en)
|
2012-04-27 |
2017-08-01 |
葛蘭素集團有限公司 |
Compounds useful as retinoid-related orphan receptor gamma (ror γ) modulators, the pharmaceutical compositions and use thereof
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
EP2844259A4
(en)
|
2012-04-30 |
2015-11-11 |
Anderson Gaweco |
Ror modulators and their uses
|
JP6242868B2
(en)
|
2012-05-08 |
2017-12-06 |
リセラ・コーポレイションLycera Corporation |
Tetrahydro [1,8] naphthyridinesulfonamide and related compounds for use as agonists of RORγ and for the treatment of diseases
|
JP6236067B2
(en)
|
2012-05-08 |
2017-11-22 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
Bicyclic sulfone compounds for inhibiting RORγ activity and treating diseases
|
KR20150007300A
(en)
|
2012-05-08 |
2015-01-20 |
머크 샤프 앤드 돔 코포레이션 |
TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
|
EA201791271A1
(en)
|
2012-05-31 |
2018-01-31 |
Фенекс Фармасьютикалз Аг |
THIAZOLES, SUBSTITUTED BY CARBOXAMIDE OR SULPHONAMIDE AND RELATED DERIVATIVES AS MODULATORS FOR ORPHANIC NUCLEAR RORγ RECEPTOR
|
AR091654A1
(en)
|
2012-07-02 |
2015-02-18 |
Biogen Idec Inc |
COMPOUNDS CONTAINING BIARILO AS INVESTED AGONISTS OF ROR-g RECEIVERS
|
TW201408652A
(en)
|
2012-07-11 |
2014-03-01 |
Hoffmann La Roche |
Aryl sultam derivatives as RORc modulators
|
WO2014026328A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof
|
WO2014028669A1
(en)
|
2012-08-15 |
2014-02-20 |
Biogen Idec Ma Inc. |
Novel compounds for modulation of ror-gamma activity
|
WO2014026330A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
|
WO2014026327A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
|
WO2014026329A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
|
CN104640846A
(en)
|
2012-09-21 |
2015-05-20 |
赛诺菲 |
Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators
|
US10035790B2
(en)
|
2012-10-19 |
2018-07-31 |
Exelixis, Inc. |
RORγ modulators
|
EP3219711A1
(en)
|
2012-12-06 |
2017-09-20 |
Glaxo Group Limited |
Modulators of the retinoid-related orphan receptor gamma (ror-gamma) for use in the treatment of autoimmune and inflammatory diseases
|
WO2013171729A2
(en)
|
2013-01-08 |
2013-11-21 |
Glenmark Pharmaceuticals S.A. |
Aryl and heteroaryl amide compounds as rorgamat modulator
|
WO2014110442A1
(en)
|
2013-01-10 |
2014-07-17 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
WO2014179564A1
(en)
|
2013-05-01 |
2014-11-06 |
Vitae Pharmaceuticals, Inc. |
Thiazalopyrrolidine inhibitors of ror-gamma
|
EP3027616B1
(en)
|
2013-07-30 |
2018-01-10 |
Boehringer Ingelheim International GmbH |
Azaindole compounds as modulators of rorc
|
WO2015035032A1
(en)
|
2013-09-05 |
2015-03-12 |
Boehringer Ingelheim International Gmbh |
Bicylic compounds as modulators of rorgamma
|
TWI652014B
(en)
|
2013-09-13 |
2019-03-01 |
美商艾佛艾姆希公司 |
Heterocyclic substituted bicycloazole insecticide
|
KR20160070162A
(en)
|
2013-11-05 |
2016-06-17 |
에프. 호프만-라 로슈 아게 |
5,6,7,8-TETRAHYDRO-5,8-METHANOCINNOLINE DERIVATIVES AS RORc MODULATORS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
|
WO2015083130A1
(en)
|
2013-12-06 |
2015-06-11 |
Aurigene Discovery Technologies Limited |
Fused pyridine and pyrimidine derivatives as ror gamma modulators
|
MX361652B
(en)
|
2013-12-24 |
2018-12-13 |
Harvard College |
Cortistatin analogues and syntheses and uses thereof.
|
JP2015124178A
(en)
|
2013-12-26 |
2015-07-06 |
東レ株式会社 |
Cyclic amine derivative and medicinal use thereof
|
WO2015101928A1
(en)
|
2013-12-31 |
2015-07-09 |
Aurigene Discovery Technologies Limited |
Fused thiophene and thiazole derivatives as ror gamma modulators
|
CA2938311C
(en)
|
2014-02-03 |
2023-03-07 |
Vitae Pharmaceuticals, Inc. |
Dihydropyrrolopyridine inhibitors of ror-gamma
|
EP3102563B1
(en)
|
2014-02-03 |
2019-04-10 |
Basf Se |
Cyclopentene and cyclopentadiene compounds for controlling invertebrate pests
|
JO3512B1
(en)
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
Quinoxaline derivatives useful as fgfr kinase modulators
|
US9815798B2
(en)
|
2014-03-26 |
2017-11-14 |
Basf Se |
Substituted [1,2,4]triazole and imidazole compounds as fungicides
|
ES2753549T3
(en)
|
2014-03-26 |
2020-04-13 |
Hoffmann La Roche |
Bicyclic compounds as inhibitors of the production of autotaxin (ATX) and lysophosphatidic acid (LPA)
|
KR20160128428A
(en)
|
2014-03-26 |
2016-11-07 |
에프. 호프만-라 로슈 아게 |
Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
|
CA2940264A1
(en)
|
2014-04-16 |
2015-10-22 |
Glenmark Pharmaceuticals S.A. |
Aryl and heteroaryl ether compounds as ror gamma modulators
|
TWI675032B
(en)
*
|
2014-10-14 |
2019-10-21 |
美商維它藥物公司 |
Dihydropyrrolopyridine inhibitors of ror-gamma
|
CA2965336A1
(en)
|
2014-10-22 |
2016-04-28 |
The Board Of Regents Of The University Of Texas System |
Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof
|
US9663515B2
(en)
*
|
2014-11-05 |
2017-05-30 |
Vitae Pharmaceuticals, Inc. |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|
CN112608300B
(en)
|
2015-03-11 |
2024-04-26 |
Fmc公司 |
Heterocyclic substituted bicyclic azole pesticides
|
DK3331876T3
(en)
|
2015-08-05 |
2021-01-11 |
Vitae Pharmaceuticals Llc |
MODULATORS OF ROR-GAMMA
|
KR20180086221A
(en)
|
2015-11-20 |
2018-07-30 |
비타이 파마슈티컬즈, 인코포레이티드 |
Regulators of ROR-gamma
|
TW202220968A
(en)
|
2016-01-29 |
2022-06-01 |
美商維它藥物有限責任公司 |
Modulators of ror-gamma
|
US9481674B1
(en)
*
|
2016-06-10 |
2016-11-01 |
Vitae Pharmaceuticals, Inc. |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|
WO2019018975A1
(en)
|
2017-07-24 |
2019-01-31 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of ror gamma
|
RU2020107919A
(en)
|
2017-07-24 |
2021-08-25 |
Вайтаи Фармасьютиклз, Ллк. |
ROR INHIBITORS
|